Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Invitae Common Hereditary Cancers + RNA Panel Invitae United States | 114 | 47 |
|
GeneID Lab - Advanced Molecular Diagnostics United States | 41 | 19 |
|
Ambry Genetics United States | 79 | 37 |
|
Variant Resolution Test for CancerNext® 37 (+RNAinsight®) Ambry Genetics United States | 79 | 18 |
|
Variant Resolution Test for Penn Cancer Grant Panel (+RNAinsight®) Ambry Genetics United States | 79 | 18 |
|
Ambry Genetics United States | 79 | 80 |
|
Mismatch Repair Proteins by Immunohistochemistry GoPath Diagnostics United States | 6 | 4 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Brain tumor-polyposis syndrome 2, 175100, Autosomal dominant (Turcot syndrome with polyposis) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Gardner syndrome, 175100, Autosomal dominant (Gardner syndrome) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Adenoma, periampullary, somatic (APC gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Adenomatous polyposis coli, 175100, Autosomal dominant; FAP1 (Familial adenomatous polyposis) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 21 | 9 |
|
Variant Resolution Test for CancerNext® (+RNAinsight®) Ambry Genetics United States | 55 | 34 |
|
Invitae United States | 409 | 164 |
|
Invitae United States | 160 | 62 |
|
Invitae 78 Gene Actionable Disorders Panel Invitae United States | 220 | 75 |
|
Variant Resolution Test for CustomNext-Cancer® (+RNAinsight®) Ambry Genetics United States | 147 | 18 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.